HomeStock ScreenerBiofil ChemicalsIntrinsic Value

Biofil Chemicals Intrinsic Value

Biofil Chemicals (BIOFILCHEM) median intrinsic value is ₹12.82 from 9 valuation models (range ₹10–₹44), vs current price ₹32.06 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read BIOFILCHEM ex-dividend dates for the complete payout history and dividend yield track record.

Market Price (CMP)
₹32.06
Primary Intrinsic Value
₹9.62
Market Cap
₹51.3 Cr
-60.0% Downside
Median Value
₹12.82
Value Range
₹10 - ₹44
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

BIOFILCHEM Valuation Methods Summary — DCF, Graham Number & P/E

Biofil Chemicals intrinsic value across 9 models vs current price ₹32.06 — upside/downside and value range per method. Compare with BIOFILCHEM fundamental valuation to assess whether the stock is under or overvalued.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹9.62 ₹7.70 - ₹11.54 -70.0% EPS: ₹0.30, Sector P/E: 22x
Book Value Method asset ₹23.75 ₹21.38 - ₹26.13 -25.9% Book Value/Share: ₹11.88, P/B: 2.0x
Revenue Multiple Method revenue ₹43.75 ₹39.38 - ₹48.13 +36.5% Revenue/Share: ₹21.88, P/S: 2.0x
EBITDA Multiple Method earnings ₹12.82 ₹11.54 - ₹14.10 -60.0% EBITDA: ₹1.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹16.98 ₹13.58 - ₹20.38 -47.0% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹9.62 ₹8.66 - ₹10.58 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹9.62 ₹8.66 - ₹10.58 -70.0% Revenue Growth: 3.9%, Adj P/E: 15.3x
ROE Based Valuation profitability ₹16.03 ₹14.43 - ₹17.63 -50.0% ROE: 5.3%, P/E Multiple: 10x
Graham Defensive Method conservative ₹9.62 ₹8.66 - ₹10.58 -70.0% EPS: ₹0.30, BVPS: ₹11.88
Method Types: Earnings Asset DCF Growth Dividend Conservative

BIOFILCHEM Intrinsic Value vs Market Price — All Valuation Models

Biofil Chemicals fair value range ₹10–₹44 vs current market price ₹32.06 across 9 valuation models. For current market price and key ratios, visit Biofil Chemicals stock price NSE.

BIOFILCHEM Intrinsic Value Analysis — Undervalued or Overvalued?

Biofil Chemicals median intrinsic value ₹12.82, current price ₹32.06 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.

What is the intrinsic value of BIOFILCHEM?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Biofil Chemicals (BIOFILCHEM) is ₹12.82 (median value). With the current market price of ₹32.06, this represents a -60.0% variance from our estimated fair value.

The valuation range spans from ₹9.62 to ₹43.75, indicating ₹9.62 - ₹43.75.

Is BIOFILCHEM undervalued or overvalued?

Based on our multi-method analysis, Biofil Chemicals (BIOFILCHEM) appears to be trading above calculated value by approximately 60.0%.

BIOFILCHEM Financial Health — Key Ratios vs Industry Benchmarks

Biofil Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 5.3% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 5.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.69x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

BIOFILCHEM Cash Flow Quality — Operating & Free Cash Flow

Biofil Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹-2 Cr ₹-2 Cr Negative Cash Flow 3/10
March 2024 ₹2 Cr ₹2 Cr Positive Free Cash Flow 8/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2021 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10